Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
The following is a summary of “Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions With Large ...
When choosing how to reduce the risk of stroke, a clinician uses tools to estimate the risk of stroke and serious bleeding ...
Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical t ...
RenovoRx (NASDAQ: RNXT) , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath(R), a novel, FDA-cleare ...
Regeneron Pharmaceuticals Inc. (REGN) announced encouraging outcomes from the Phase 3 QUASAR trial, which evaluated the efficacy of ...
The following is a summary of “Associations between a healthy lifestyle score and retinal neurovascular health,” published in ...
In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.